Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
2011
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Nonclassic Congenital Adrenal Hyperplasia
2010
Function of alternative splicing
2004
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
What every physician should know about polycystic ovary syndrome
2008
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
2011
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
2010
ROS production and protein oxidation as a novel mechanism for seed dormancy alleviation
2007 Standout
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
1997 Standout
Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
2011
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
2002
The adrenal and polycystic ovary syndrome
2007
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
2012
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
2006
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
2012
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome
2006
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
1999
Surgical treatment of primary lung cancer with synchronous brain metastases
2001
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
2014
DHEA, DHEAS and PCOS
2014
Lung cancer screening with spiral CT
2007
A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis
2002
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
2008
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
2004
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
2006
Immediate Postoperative Enteral Feeding Results in Impaired Respiratory Mechanics and Decreased Mobility
1997
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome
2008
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Elastic sealants for surgical applications
2015
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
2014
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Polycystic Ovary Syndrome
1995 Standout
Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome
2004
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Practice parameters for the management of single brain metastasis
2000
Acne vulgaris
2011 Standout
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Resection for solitary brain metastasis
1992
Dry double-sided tape for adhesion of wet tissues and devices
2019 StandoutNature
Polycystic Ovary Syndrome
2005 Standout
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
2011
A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
2001
Polycystic ovary syndrome and hyperprolactinemia are distinct entities
2007
Epoxide hydrolases: their roles and interactions with lipid metabolism
2005
Adolescent Anovulation: Maturational Mechanisms and Implications
2013
Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
1999
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS
2007
Surgical Management of Non-small Cell Lung Cancer With Synchronous Brain Metastases
2001
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Surgical Management of Oligometastatic Non–Small Cell Lung Cancer
2016
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma
2006
Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
2012
Androgen excess: Investigations and management
2016
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Disorders of the Aldosterone Synthase and Steroid 11β-Hydroxylase Deficiencies
1999
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Contemporary Aspects of Discrete Peak-Detection Algorithms. II. The Paradigm of the Luteinizing Hormone Pulse Signal in Women*
1992
Human gelatin tissue-adhesive hydrogels prepared by enzyme-mediated biosynthesis of DOPA and Fe3+ion crosslinking
2013
HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS
1989
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
2010
Polycystic ovary syndrome
2016 Standout
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
2015
Carbonic Anhydrase IX: Regulation and Role in Cancer
2013
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
2012
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms
2009
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
2009
The role of DNA repair capacity in susceptibility to lung cancer: A review
1997
Special Treatment Issues in Non-small Cell Lung Cancer
2013
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Visually scoring hirsutism
2009
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
2009
Spironolactone as a single agent for long‐term therapy of hirsute patients
2000
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
2017
Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial
2013
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
2015
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
2013 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force
2013
Homeostatic Responses in the Adrenal Cortex to the Absence of Aldosterone in Mice
2005 StandoutNobel
Clinical and Biological Phenotypes in Late-Onset 21 Hydroxylase Deficiency
1986
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
2007
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff.
1992
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Polycystic Ovarian Morphology in Normal Women Does Not Predict the Development of Polycystic Ovary Syndrome
2006
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
11β-Hydroxylase deficiency in hyperandrogenism
1991
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
2012
Combination therapy in combating cancer
2017 Standout
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
2011
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
2012
AN INTRODUCTION TO TRP CHANNELS
2005 Standout
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
2015
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline
2019
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
1995
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
1995
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
STUDIES OF PROLACTIN SECRETION IN POLYCYSTIC OVARY SYNDROME
1986
Works of A Janní being referenced
Prevalence of late-onset 11 β-hydroxylase-deficiency in hirsute patients
1988
Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
2006
Resection of single brain metastasis in non-small-cell lung cancer: Prognostic factors
1996
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer
2006
Thoracoscopic localization techniques for patients with solitary pulmonary nodule: hookwire versus radio-guided surgery☆
2007
Safety and Effectiveness of a New Fibrin Pleural Air Leak Sealant: A Multicenter, Controlled, Prospective, Parallel-Group, Randomized Clinical Trial
2011
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer
2008
Increased circulating levels of immunoreactive β-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion
1992
Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial
2011
Gender differences in non-small cell lung cancer: A population-based study
2007
Energy Metabolism of Thoracic Surgical Patients in the Early Postoperative Period
1996
Second primary lung cancer and relapse: treatment and follow-up
1995
Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern
1984
Physiological Estrogen Replacement May Enhance the Effectiveness of the Gonadotropin-Releasing Hormone Agonist in the Treatment of Hirsutism
1994
The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency)
1984
Surgical treatment of primary lung cancer and solitary brain metastasis.
1985
Cigarette Smoke Inhibits Cytosolic but not Microsomal Epoxide Hydrolase of Human Lung
1992
Gonadotropic Therapy in Men with Hypogonadotropic Hypogonadism
1984
Hypogonadism in a male with immunologically active, biologically inactive luteinizing hormone.
1980
Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients
1986
Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
1994
P-271 ITALUNG_CT screening for lung cancer: Preliminary results
2005